Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM
Bao Liu, Qifeng Ji, Ying Cheng, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Ferroptosis: a double-edged sword mediating immune tolerance of cancer
Qin Dang, Ziqi Sun, Yang Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 72
Interrelation between Programmed Cell Death and Immunogenic Cell Death: Take Antitumor Nanodrug as an Example
Qi Meng, Binbin Ding, Ping’an Ma, et al.
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 48
Orthotopic and metastatic tumour models in preclinical cancer research
Stephen M. Stribbling, Callum Beach, Anderson J. Ryan
Pharmacology & Therapeutics (2024) Vol. 257, pp. 108631-108631
Open Access | Times Cited: 19
Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
Young‐Jin Choi, Su Hyun Seok, Hong Yeol Yoon, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115306-115306
Open Access | Times Cited: 19
Ferroptosis: Promising approach for cancer and cancer immunotherapy
Shuyue Zheng, Xin‐Yuan Guan
Cancer Letters (2023) Vol. 561, pp. 216152-216152
Closed Access | Times Cited: 38
Immune cells: potential carriers or agents for drug delivery to the central nervous system
Shanshan Zhang, Ruo-Qi Li, Zhong Chen, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 10
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 8
Lactoferrin Nanoparticle-Vanadium Complex: A Promising High-Efficiency Agent against Glioblastoma by Triggering Autophagy and Ferroptosis
Shuangshuang Gai, Qiwei Yan, Shan Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects
Y. F. Lu, Xiao‐Ting Xie, Lianxiang Luo
APOPTOSIS (2024) Vol. 29, Iss. 11-12, pp. 1914-1943
Closed Access | Times Cited: 7
Glutathione Depletion‐Induced Versatile Nanomedicine for Potentiating the Ferroptosis to Overcome Solid Tumor Radioresistance and Enhance Immunotherapy
Huijuan Song, Hao Sun, Ningning He, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 9
Closed Access | Times Cited: 6
ROS regulation in gliomas: implications for treatment strategies
Yuchen Yang, Yu Zhu, Si-Jia Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction
Xue Li, Ying Cheng, Zhifu Yang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Multifunctional Fe3O4-PEI@HA nanoparticles in the ferroptosis treatment of hepatocellular carcinoma through modulating reactive oxygen species
Ziwei Liang, Yuhui Wang, Jiapu Wang, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 227, pp. 113358-113358
Closed Access | Times Cited: 12
Progress in the Mechanism of the Effect of Fe3O4 Nanomaterials on Ferroptosis in Tumor Cells
Yaxuan Wang, Xiao Wu, Xiaoying Bao, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4562-4562
Open Access | Times Cited: 11
Ferroptosis, a subtle talk between immune system and cancer cells: To be or not to be?
Qiong Zhou, Chunyu Tao, Jiakai Yuan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115251-115251
Open Access | Times Cited: 11
Therapeutic and prognostic values of ferroptosis signature in glioblastoma
Reza Nedaeinia, Hassan Dianat‐Moghadam, Maedeh Movahednasab, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114597-114597
Closed Access
Lipotoxicity, lipid peroxidation and ferroptosis: a dilemma in cancer therapy
Chuhan Ma, Hui‐xin Hu, Hao Liu, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Opportunities and challenges related to ferroptosis in glioma and neuroblastoma
Huizhong Chi, Boyan Li, Qingtong Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature
Yongqing Yang, Nianlan Cheng, Qiao Luo, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3663-3694
Open Access | Times Cited: 9
Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds
Qiuran Liang, Yuehui Wang, Yili Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
The Mutual Regulatory Role of Ferroptosis and Immunotherapy in Anti-tumor Therapy
Zhiguo Mao, Yilong Hu, Yinan Zhao, et al.
APOPTOSIS (2024)
Open Access | Times Cited: 3
Emerging advances in drug delivery systems (DDSs) for optimising cancer complications
Kerui Li, Bei Guo, Junhao Gu, et al.
Materials Today Bio (2024) Vol. 30, pp. 101375-101375
Open Access | Times Cited: 3
Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy
Zahra Fekrirad, Amir Barzegar Behrooz, Shokoofeh Ghaemi, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3698-3698
Open Access | Times Cited: 13
Recent advances in ferroptosis and therapeutic strategies for glioblastoma
Qixiong Lu, Xiaoyang Lu, Yuansheng Zhang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 9
Open Access | Times Cited: 7
FHOD1 is upregulated in glioma cells and attenuates ferroptosis of glioma cells by targeting HSPB1 signaling
Fan Zhang, Lixiang Wu, Songshan Feng, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 11, pp. 3351-3363
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top